Veradermics Inc. Insider Trading

MANE

Last 12 months

Insiders bought $25.3M and sold $22.7M on the open market.

53% of the selling was scheduled in advance under 10b5-1 plans. Director John W Childs sold $10.7M on Aug 12, 34% of their stake, outside a plan.

Net open-market

+$2.59M

3 buys · 3 sales

Under a 10b5-1 plan

53%

of the value sold

Insiders who bought / sold

3 / 3

executives and directors

Last open-market buy

Feb 2026

Feb 5, 2026

Get an email when MANE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19	Averill Master Fund, Ltd. Large holder	SoldNo plan 2 parts	750,000	$107.25 average	$80.4M	55%	Form 4
Aug 17	Timothy August Durso Chief Technical Officer	Sold10b5-1 plan 5 parts	43,500	$107.82 average	$4.69M	36%	Form 4
Aug 17	Reid Alexander Waldman Chief Executive Officer	Sold10b5-1 plan 5 parts	67,500	$107.86 average	$7.28M	28%	Form 4
Aug 12	John W Childs Director	SoldNo plan 3 parts	100,000	$107.12 average	$10.7M	34%	Form 4
Feb 4 – 6	Suvretta Capital Management, LLC Large holder	Bought 19 parts	282,674	$37.30 average	$10.5M	119%	Form 4
Feb 5	John W Childs Director	Bought	294,117	$17.00	$5M	New	Form 4
Feb 5	Vlad Coric Director	Bought 2 parts	117,646	$17.00 average	$2M	18%	Form 4
Feb 5	Longitude Venture Partners V, L.p. Large holder	Bought 2 parts	1,075,000	$17.00 average	$18.3M	110%	Form 4
Feb 5	Patrick G Enright Director	Bought 2 parts	1,075,000	$17.00 average	$18.3M	110%	Form 4

Aug 19No plan
Averill Master Fund, Ltd.
Large holder · sold 750,000 at avg $107.25
$80.4M
55% of stake
Aug 1710b5-1 plan
Timothy August Durso
Chief Technical Officer · sold 43,500 at avg $107.82
$4.69M
36% of stake
Aug 1710b5-1 plan
Reid Alexander Waldman
Chief Executive Officer · sold 67,500 at avg $107.86
$7.28M
28% of stake
Aug 12No plan
John W Childs
Director · sold 100,000 at avg $107.12
$10.7M
34% of stake
Feb 4 – 6
Suvretta Capital Management, LLC
Large holder · bought 282,674 at avg $37.30
$10.5M
119% of stake
Feb 5
John W Childs
Director · bought 294,117 at $17.00
$5M
New position
Feb 5
Vlad Coric
Director · bought 117,646 at avg $17.00
$2M
18% of stake
Feb 5
Longitude Venture Partners V, L.p.
Large holder · bought 1,075,000 at avg $17.00
$18.3M
110% of stake
Feb 5
Patrick G Enright
Director · bought 1,075,000 at avg $17.00
$18.3M
110% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MANE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MANE

CompareIntrinsic value

NGNENeurogene Inc.

$27.58+3.41%10

MREOMereo BioPharma Group plc

$0.30+4.12%10

COYACoya Therapeutics Inc.

$3.08-0.96%10

PRLDPrelude Therapeutics Incorporated

$4.08+7.94%40

PLRXPliant Therapeutics Inc.

$0.85-1.07%10

AARDAardvark Therapeutics, Inc.

$1.26+2.44%10

ORMPOramed Pharmaceuticals Inc.

$4.13+3.25%35

NTHINeonC Technologies Holdings

$3.17+3.26%10

Held by ETFs

MANE is in 29 US ETFs. The largest of them, with MANE's weight in each:

Spot a number that looks wrong? Check it in MANE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MANE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.